LPTX
NASDAQ
$2.05
Leap Therapeutics Inc (LPTX)
Leap Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to the development of groundbreaking cancer therapies. The company specializes in precision medicine, with a robust pipeline of innovative treatments targeting specific oncogenic pathways to address significant unmet medical needs in oncology. By leveraging its expertise and commitment to advancing cancer care, Leap Therapeutics aims to improve patient outcomes and position itself as a key player in the evolving healthcare landscape.
Sector:
Healthcare
Industry:
Biotechnology
Strong Sell
Target: $3 (+46.34%)
Market Cap
$85M
Free Cash Flow Yield
-70.88%
Beta (5Y)
1.36
Price Chart
Valuation
Market Cap$85M
P/S8475.88
P/B14.83
Profitability
Total Revenue (TTM)$375K
Gross Profit (TTM)$1.50M
EBITDA-$63M
EPS-$1.58
Financial Health
Debt-to-Equity0.7%
Free Cash Flow Yield-70.88%
Growth & Risk
Revenue 5Y CAGR-57.83%
Beta (5Y)1.36
Sharpe Ratio0.73